BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringsmöjlighet: Allergimarknaden är enorm – AcuCort har en unik position (annons)

Pressmeddelande

BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.

MFN Publicerad: 28 Aug 2023 08:30
BrainCool

Publication of BrainCool AB's report for the second quarter will be brought forward to today, August 28, 2023. The previously announced date for publication was August 31, 2023.
 
The reason why the company brings forward the financial report is that the report became ready earlier as a result of the targeted new share issue that was decided on earlier today.

Contacts
For more information
Martin Waleij - CEO
+46 - 733 -93 70 76
E-mail: [email protected]         

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

Attachments
BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.

Bifogade filer

BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.https://storage.mfn.se/2ed1abe9-f281-41ae-92a3-5e6d1f2353cb/braincool-ab-publ-publication-of-braincool-abs-interim-report-for-q2-will-be-brought-forward-to-today-august-28-2023.pdf

Nyheter om BrainCool

Läses av andra just nu

Om aktien BrainCool

Senaste nytt